184 related articles for article (PubMed ID: 23523916)
1. MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.
Qin W; Ren Q; Liu T; Huang Y; Wang J
FEBS Lett; 2013 May; 587(9):1434-9. PubMed ID: 23523916
[TBL] [Abstract][Full Text] [Related]
2. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
3. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H
Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971
[TBL] [Abstract][Full Text] [Related]
6. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X
Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953
[TBL] [Abstract][Full Text] [Related]
8. miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1.
Guo J; Xia B; Meng F; Lou G
Biochem Biophys Res Commun; 2013 Nov; 441(2):357-63. PubMed ID: 24144591
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
Guo LM; Pu Y; Han Z; Liu T; Li YX; Liu M; Li X; Tang H
FEBS J; 2009 Oct; 276(19):5537-46. PubMed ID: 19702828
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.
Xia Y; Gao Y
Biochem Biophys Res Commun; 2014 May; 447(3):446-51. PubMed ID: 24735543
[TBL] [Abstract][Full Text] [Related]
11. MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer.
Zhang F; Yang Z; Cao M; Xu Y; Li J; Chen X; Gao Z; Xin J; Zhou S; Zhou Z; Yang Y; Sheng W; Zeng Y
Cancer Lett; 2014 Jan; 342(1):121-9. PubMed ID: 24001611
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of microRNA-98 inhibits cell proliferation and promotes cell apoptosis via claudin-1 in human colorectal carcinoma.
Zheng YF; Luo J; Gan GL; Li W
J Cell Biochem; 2019 Apr; 120(4):6090-6105. PubMed ID: 30506722
[TBL] [Abstract][Full Text] [Related]
13. An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.
Wynendaele J; Böhnke A; Leucci E; Nielsen SJ; Lambertz I; Hammer S; Sbrzesny N; Kubitza D; Wolf A; Gradhand E; Balschun K; Braicu I; Sehouli J; Darb-Esfahani S; Denkert C; Thomssen C; Hauptmann S; Lund A; Marine JC; Bartel F
Cancer Res; 2010 Dec; 70(23):9641-9. PubMed ID: 21084273
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met.
Hu Z; Lin Y; Chen H; Mao Y; Wu J; Zhu Y; Xu X; Xu X; Li S; Zheng X; Xie L
Biochem Biophys Res Commun; 2013 May; 435(1):82-7. PubMed ID: 23618864
[TBL] [Abstract][Full Text] [Related]
15. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
16. miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1.
Tang H; Yao L; Tao X; Yu Y; Chen M; Zhang R; Xu C
Int J Mol Med; 2013 Aug; 32(2):381-8. PubMed ID: 23722670
[TBL] [Abstract][Full Text] [Related]
17. miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1.
Mahati S; Xiao L; Yang Y; Mao R; Bao Y
Biochem Biophys Res Commun; 2017 May; 486(3):732-737. PubMed ID: 28342862
[TBL] [Abstract][Full Text] [Related]
18. MiR-410 regulates MET to influence the proliferation and invasion of glioma.
Chen L; Zhang J; Feng Y; Li R; Sun X; Du W; Piao X; Wang H; Yang D; Sun Y; Li X; Jiang T; Kang C; Li Y; Jiang C
Int J Biochem Cell Biol; 2012 Nov; 44(11):1711-7. PubMed ID: 22750473
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth.
He XP; Shao Y; Li XL; Xu W; Chen GS; Sun HH; Xu HC; Xu X; Tang D; Zheng XF; Xue YP; Huang GC; Sun WH
FEBS J; 2012 Nov; 279(22):4201-12. PubMed ID: 23013439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]